Table of Contents


Population Criteria

        • "Encounter With Age Range and Without VTE Diagnosis or Obstetrical Conditions"
         
        • "Encounter With ICU Location"
         
        • "Encounter With ICU Location And Encounter Less Than 2 Days"
            union "Encounter With First ICU Stay With Principal Procedure of SCIP VTE Selected Surgery"
            union "Encounter With Intervention Comfort Measures From Day Of Start of Hospitalization To Day After First ICU Stay"
            union "Encounter With Intervention Comfort Measures on Day of or Day After Procedure"
         
        • "Encounter With VTE Prophylaxis Received on Day of or Day After First ICU Stay or Procedure"
            union ( "Encounter With Medication Oral Factor Xa Inhibitor Administered on Day of or Day After First ICU Stay or Procedure"
                intersect ( "Encounter With Prior or Present Diagnosis of Atrial Fibrillation or VTE"
                    union "Encounter With Prior or Present Procedure of Hip or Knee Replacement Surgery"
                )
            )
            union "Encounter With Low Risk for VTE or Anticoagulant Administered"
            union "Encounter With No VTE Prophylaxis Due to Medical Reason"
            union "Encounter With No VTE Prophylaxis Due to Patient Refusal"
         
        • None
         
        • "Encounter With First ICU Location Stay Less Than 1 day"
         
        • None
         
  • Definitions

    Functions

    Terminology

    • code "Birth date" ("LOINC Code (21112-8)")
    • code "Risk for venous thromboembolism" ("LOINC Code (72136-5)")
    • valueset "Atrial Fibrillation/Flutter" (2.16.840.1.113883.3.117.1.7.1.202)
    • valueset "Comfort Measures" (1.3.6.1.4.1.33895.1.3.0.45)
    • valueset "Direct Thrombin Inhibitor" (2.16.840.1.113883.3.117.1.7.1.205)
    • valueset "Emergency Department Visit" (2.16.840.1.113883.3.117.1.7.1.292)
    • valueset "Encounter Inpatient" (2.16.840.1.113883.3.666.5.307)
    • valueset "Ethnicity" (2.16.840.1.114222.4.11.837)
    • valueset "General or Neuraxial Anesthesia" (2.16.840.1.113883.3.666.5.1743)
    • valueset "General Surgery" (2.16.840.1.113883.3.117.1.7.1.255)
    • valueset "Glycoprotein IIb/IIIa Inhibitors" (2.16.840.1.113762.1.4.1045.41)
    • valueset "Graduated compression stockings (GCS)" (2.16.840.1.113883.3.117.1.7.1.256)
    • valueset "Gynecological Surgery" (2.16.840.1.113883.3.117.1.7.1.257)
    • valueset "Hip Fracture Surgery" (2.16.840.1.113883.3.117.1.7.1.258)
    • valueset "Hip Replacement Surgery" (2.16.840.1.113883.3.117.1.7.1.259)
    • valueset "Injectable Factor Xa Inhibitor for VTE Prophylaxis" (2.16.840.1.113883.3.117.1.7.1.211)
    • valueset "INR" (2.16.840.1.113883.3.117.1.7.1.213)
    • valueset "Intensive Care Unit" (2.16.840.1.113762.1.4.1029.206)
    • valueset "Intermittent pneumatic compression devices (IPC)" (2.16.840.1.113883.3.117.1.7.1.214)
    • valueset "Intracranial Neurosurgery" (2.16.840.1.113883.3.117.1.7.1.260)
    • valueset "Intravenous route" (2.16.840.1.113883.3.117.1.7.1.222)
    • valueset "Knee Replacement Surgery" (2.16.840.1.113883.3.117.1.7.1.261)
    • valueset "Low Dose Unfractionated Heparin for VTE Prophylaxis" (2.16.840.1.113762.1.4.1045.39)
    • valueset "Low Molecular Weight Heparin for VTE Prophylaxis" (2.16.840.1.113883.3.117.1.7.1.219)
    • valueset "Low Risk" (2.16.840.1.113883.3.117.1.7.1.400)
    • valueset "Medical Reason" (2.16.840.1.113883.3.117.1.7.1.473)
    • valueset "Observation Services" (2.16.840.1.113762.1.4.1111.143)
    • valueset "Obstetrics" (2.16.840.1.113883.3.117.1.7.1.263)
    • valueset "Obstetrics VTE" (2.16.840.1.113883.3.117.1.7.1.264)
    • valueset "ONC Administrative Sex" (2.16.840.1.113762.1.4.1)
    • valueset "Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" (2.16.840.1.113883.3.117.1.7.1.134)
    • valueset "Patient Refusal" (2.16.840.1.113883.3.117.1.7.1.93)
    • valueset "Payer" (2.16.840.1.114222.4.11.3591)
    • valueset "Race" (2.16.840.1.114222.4.11.836)
    • valueset "Rivaroxaban and Betrixaban for VTE Prophylaxis" (2.16.840.1.113762.1.4.1110.50)
    • valueset "Subcutaneous route" (2.16.840.1.113883.3.117.1.7.1.223)
    • valueset "Unfractionated Heparin" (2.16.840.1.113883.3.117.1.7.1.218)
    • valueset "Urological Surgery" (2.16.840.1.113883.3.117.1.7.1.272)
    • valueset "Venous foot pumps (VFP)" (2.16.840.1.113883.3.117.1.7.1.230)
    • valueset "Venous Thromboembolism" (2.16.840.1.113883.3.117.1.7.1.279)
    • valueset "Warfarin" (2.16.840.1.113883.3.117.1.7.1.232)

    Data Criteria (QDM Data Elements)

    • "Assessment, Performed: Risk for venous thromboembolism" using "Risk for venous thromboembolism (LOINC Code 72136-5)"
    • "Device, Applied: Graduated compression stockings (GCS)" using "Graduated compression stockings (GCS) (2.16.840.1.113883.3.117.1.7.1.256)"
    • "Device, Applied: Intermittent pneumatic compression devices (IPC)" using "Intermittent pneumatic compression devices (IPC) (2.16.840.1.113883.3.117.1.7.1.214)"
    • "Device, Applied: Venous foot pumps (VFP)" using "Venous foot pumps (VFP) (2.16.840.1.113883.3.117.1.7.1.230)"
    • "Device, Not Applied: Graduated compression stockings (GCS)" using "Graduated compression stockings (GCS) (2.16.840.1.113883.3.117.1.7.1.256)"
    • "Device, Not Applied: Intermittent pneumatic compression devices (IPC)" using "Intermittent pneumatic compression devices (IPC) (2.16.840.1.113883.3.117.1.7.1.214)"
    • "Device, Not Applied: Venous foot pumps (VFP)" using "Venous foot pumps (VFP) (2.16.840.1.113883.3.117.1.7.1.230)"
    • "Device, Not Ordered: Graduated compression stockings (GCS)" using "Graduated compression stockings (GCS) (2.16.840.1.113883.3.117.1.7.1.256)"
    • "Device, Not Ordered: Intermittent pneumatic compression devices (IPC)" using "Intermittent pneumatic compression devices (IPC) (2.16.840.1.113883.3.117.1.7.1.214)"
    • "Device, Not Ordered: Venous foot pumps (VFP)" using "Venous foot pumps (VFP) (2.16.840.1.113883.3.117.1.7.1.230)"
    • "Diagnosis: Atrial Fibrillation/Flutter" using "Atrial Fibrillation/Flutter (2.16.840.1.113883.3.117.1.7.1.202)"
    • "Diagnosis: Venous Thromboembolism" using "Venous Thromboembolism (2.16.840.1.113883.3.117.1.7.1.279)"
    • "Encounter, Performed: Emergency Department Visit" using "Emergency Department Visit (2.16.840.1.113883.3.117.1.7.1.292)"
    • "Encounter, Performed: Encounter Inpatient" using "Encounter Inpatient (2.16.840.1.113883.3.666.5.307)"
    • "Encounter, Performed: Observation Services" using "Observation Services (2.16.840.1.113762.1.4.1111.143)"
    • "Intervention, Order: Comfort Measures" using "Comfort Measures (1.3.6.1.4.1.33895.1.3.0.45)"
    • "Intervention, Performed: Comfort Measures" using "Comfort Measures (1.3.6.1.4.1.33895.1.3.0.45)"
    • "Laboratory Test, Performed: INR" using "INR (2.16.840.1.113883.3.117.1.7.1.213)"
    • "Medication, Administered: Direct Thrombin Inhibitor" using "Direct Thrombin Inhibitor (2.16.840.1.113883.3.117.1.7.1.205)"
    • "Medication, Administered: Glycoprotein IIb/IIIa Inhibitors" using "Glycoprotein IIb/IIIa Inhibitors (2.16.840.1.113762.1.4.1045.41)"
    • "Medication, Administered: Injectable Factor Xa Inhibitor for VTE Prophylaxis" using "Injectable Factor Xa Inhibitor for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.211)"
    • "Medication, Administered: Low Dose Unfractionated Heparin for VTE Prophylaxis" using "Low Dose Unfractionated Heparin for VTE Prophylaxis (2.16.840.1.113762.1.4.1045.39)"
    • "Medication, Administered: Low Molecular Weight Heparin for VTE Prophylaxis" using "Low Molecular Weight Heparin for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.219)"
    • "Medication, Administered: Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" using "Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment (2.16.840.1.113883.3.117.1.7.1.134)"
    • "Medication, Administered: Rivaroxaban and Betrixaban for VTE Prophylaxis" using "Rivaroxaban and Betrixaban for VTE Prophylaxis (2.16.840.1.113762.1.4.1110.50)"
    • "Medication, Administered: Unfractionated Heparin" using "Unfractionated Heparin (2.16.840.1.113883.3.117.1.7.1.218)"
    • "Medication, Administered: Warfarin" using "Warfarin (2.16.840.1.113883.3.117.1.7.1.232)"
    • "Medication, Not Administered: Injectable Factor Xa Inhibitor for VTE Prophylaxis" using "Injectable Factor Xa Inhibitor for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.211)"
    • "Medication, Not Administered: Low Dose Unfractionated Heparin for VTE Prophylaxis" using "Low Dose Unfractionated Heparin for VTE Prophylaxis (2.16.840.1.113762.1.4.1045.39)"
    • "Medication, Not Administered: Low Molecular Weight Heparin for VTE Prophylaxis" using "Low Molecular Weight Heparin for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.219)"
    • "Medication, Not Administered: Rivaroxaban and Betrixaban for VTE Prophylaxis" using "Rivaroxaban and Betrixaban for VTE Prophylaxis (2.16.840.1.113762.1.4.1110.50)"
    • "Medication, Not Administered: Warfarin" using "Warfarin (2.16.840.1.113883.3.117.1.7.1.232)"
    • "Medication, Not Ordered: Injectable Factor Xa Inhibitor for VTE Prophylaxis" using "Injectable Factor Xa Inhibitor for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.211)"
    • "Medication, Not Ordered: Low Dose Unfractionated Heparin for VTE Prophylaxis" using "Low Dose Unfractionated Heparin for VTE Prophylaxis (2.16.840.1.113762.1.4.1045.39)"
    • "Medication, Not Ordered: Low Molecular Weight Heparin for VTE Prophylaxis" using "Low Molecular Weight Heparin for VTE Prophylaxis (2.16.840.1.113883.3.117.1.7.1.219)"
    • "Medication, Not Ordered: Rivaroxaban and Betrixaban for VTE Prophylaxis" using "Rivaroxaban and Betrixaban for VTE Prophylaxis (2.16.840.1.113762.1.4.1110.50)"
    • "Medication, Not Ordered: Warfarin" using "Warfarin (2.16.840.1.113883.3.117.1.7.1.232)"
    • "Patient Characteristic Birthdate: Birth date" using "Birth date (LOINC Code 21112-8)"
    • "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity (2.16.840.1.114222.4.11.837)"
    • "Patient Characteristic Payer: Payer" using "Payer (2.16.840.1.114222.4.11.3591)"
    • "Patient Characteristic Race: Race" using "Race (2.16.840.1.114222.4.11.836)"
    • "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex (2.16.840.1.113762.1.4.1)"
    • "Procedure, Performed: General or Neuraxial Anesthesia" using "General or Neuraxial Anesthesia (2.16.840.1.113883.3.666.5.1743)"
    • "Procedure, Performed: General Surgery" using "General Surgery (2.16.840.1.113883.3.117.1.7.1.255)"
    • "Procedure, Performed: Gynecological Surgery" using "Gynecological Surgery (2.16.840.1.113883.3.117.1.7.1.257)"
    • "Procedure, Performed: Hip Fracture Surgery" using "Hip Fracture Surgery (2.16.840.1.113883.3.117.1.7.1.258)"
    • "Procedure, Performed: Hip Replacement Surgery" using "Hip Replacement Surgery (2.16.840.1.113883.3.117.1.7.1.259)"
    • "Procedure, Performed: Intracranial Neurosurgery" using "Intracranial Neurosurgery (2.16.840.1.113883.3.117.1.7.1.260)"
    • "Procedure, Performed: Knee Replacement Surgery" using "Knee Replacement Surgery (2.16.840.1.113883.3.117.1.7.1.261)"
    • "Procedure, Performed: Urological Surgery" using "Urological Surgery (2.16.840.1.113883.3.117.1.7.1.272)"

    Supplemental Data Elements

    Risk Adjustment Variables